AngioDynamics to Hold Fiscal 2009 Fourth Quarter and Full Year Financial Results Conference Call on July 16, 2009QUEENSBURY, N.Y.
--(BUSINESS WIRE)--Jul. 2, 2009--
, a leading provider of
innovative medical devices used by interventional radiologists and
surgeons for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will report its fiscal 2009
fourth quarter and full year financial results on Thursday, July 16,
, after the close of the financial markets.
Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk,
Executive Vice President and CFO, will host an investment community
conference call beginning at 4:30 p.m. Eastern time on July 16 to
discuss these results and to answer questions.
To participate in the live call by telephone, please dial +1 (877)
941-8609 from the U.S., or for international callers, please dial +1
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of
AngioDynamics’ Web site at http://investor.angiodynamics.com.
To listen to the live call, please go to the Web site 15 minutes prior
to its start to register, download and install the necessary audio
A replay will be available on the Web site. A telephone replay will be
available from 6:30 p.m. Eastern time on July 16, 2009, through 11:59
p.m. Eastern time on July 23 by dialing +1 (800) 406-7325 (domestic) or
+1 (303) 590-3030 (international) and entering the passcode: 4104137#.
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. The Company’s diverse product line includes market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
Source: AngioDynamics, Inc.
D. Joseph Gersuk, CFO,
800-772-6446 ext. 1608
Doug Sherk, 415-896-6820 (Investor Relations)
Kirtland, 415-896-6820 (Investor Relations)
Chris Gale, 646-201-5431 (Media)